Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2003
06/26/2003WO2003051893A2 Improvements in pharmaceutical compositions
06/26/2003WO2003051890A1 Imidazo [2,1-b]-1,3,4-thiadiazole suflonamides
06/26/2003WO2003051888A1 6-aminomorphinane derivatives, method for the production and use thereof
06/26/2003WO2003051887A1 N-carbacycle monosubstituted indolocarbazoles as protein kinase inhibitors
06/26/2003WO2003051885A1 Nitrogen-containing heterocyclic compounds and use thereof
06/26/2003WO2003051883A1 Indole derivative
06/26/2003WO2003051882A1 A2a adenosine receptor antagonists
06/26/2003WO2003051878A1 Quinolinones as prostaglandin receptor ligands
06/26/2003WO2003051874A1 Bicyclic n-arylamides
06/26/2003WO2003051873A1 Piperazine compounds and their phamaceutical use
06/26/2003WO2003051872A1 Ethylene diamine derivatives and their use as orexin-receptor antagonists
06/26/2003WO2003051869A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives
06/26/2003WO2003051868A1 Lactams as tachykinin antagonists
06/26/2003WO2003051864A1 Isoflavonoid conjugates, compositions thereof and therapeutic methods involving same
06/26/2003WO2003051863A1 SUBSTITUTED 6H-DIBENZO[c,h]CHROMENES AS ESTROGENIC AGENTS
06/26/2003WO2003051859A1 Compounds for imaging alzheimer's disease
06/26/2003WO2003051855A1 N,n'-disubstituted piperazine compounds and the use of the same as analgesics
06/26/2003WO2003051851A1 5, 6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists
06/26/2003WO2003051850A1 Pyrazine compounds and pharmaceutical compositions containing them
06/26/2003WO2003051847A1 (1-h-indazol-3-yl) -amide derivatives as gsk-3 inhibitors
06/26/2003WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051840A1 Pyrrolidine and piperidine derivates as nk1 antagonists
06/26/2003WO2003051836A1 Prodrugs to d-prolines
06/26/2003WO2003051833A2 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
06/26/2003WO2003051828A2 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
06/26/2003WO2003051819A1 Substituted 1,5-diaminopentan-3-ol compounds
06/26/2003WO2003051818A1 A novel polymorph of sertraline hydrochloride and composition containing thereof, novel methods for preparation of sertraline hydrochloride polymorphs and amorphous form
06/26/2003WO2003051807A2 Improvements in pharmaceutical compositions
06/26/2003WO2003051805A2 Substituted phenyl naphthalenes as estrogenic agents
06/26/2003WO2003051400A1 Pharmaceutical conjugates with enhanced pharmacokinetic characteristics
06/26/2003WO2003051397A1 Neuropeptide y5 receptor antagonists for treating depression, anxiety and dementia
06/26/2003WO2003051393A2 Enzymatic cleavable reagents for specific delivery to disease sites
06/26/2003WO2003051387A1 Remedies and/or preventives for conformational diseases
06/26/2003WO2003051380A2 Compositions containeing curcuma extracts for the treatment of neurocerebrovascular disorders
06/26/2003WO2003051372A1 Methods for treatment or prophylaxis of aldosterone-mediated pathogenic effectgs in a subject using an epoxy-steroidal aldosterone antagonist
06/26/2003WO2003051369A1 Pharmaceutical containing n, n'-disubstituted piperazine compounds
06/26/2003WO2003051363A1 Analgesic delivery systems and methods of use
06/26/2003WO2003051358A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/26/2003WO2003051356A1 Method for treating circadian rhythm disruptions
06/26/2003WO2003051355A1 Solid compositions containng compounds unstable to oxygen and method for stabilization thereof
06/26/2003WO2003051353A1 Substituted beta-aminoalcohols used as medicaments
06/26/2003WO2003051348A2 Composition, synthesis and therapeutic applications of polyamines
06/26/2003WO2003051340A1 New film coating
06/26/2003WO2003051333A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
06/26/2003WO2003051315A2 Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5
06/26/2003WO2003051313A2 Prevention and treatment of oxidative stress disorders by glutathione and phase ii detoxification enzymes
06/26/2003WO2003051303A2 The total synthesis of merrilactone a
06/26/2003WO2003051302A2 Methods and compositions for treatment of central nervous system disorders
06/26/2003WO2003051287A2 Topical compositions and methods for treatment of adverse effects of ionizing radiation
06/26/2003WO2003051277A2 Novel compounds
06/26/2003WO2003051276A2 Therapeutic heterocycles
06/26/2003WO2003051274A2 Benzodiazepine derivatives, preparation thereof and use thereof
06/26/2003WO2003035678A3 Sperm factor sequences
06/26/2003WO2003030920A9 An antispasmodic agent spaced drug delivery system
06/26/2003WO2003029272A3 A method of treating schizophrenia and bipolar disorders
06/26/2003WO2003020005A3 Lp mammalian proteins; related reagents
06/26/2003WO2002094202A3 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules
06/26/2003WO2002080945A3 Methods for treating the inflammatory component of a brain disorder
06/26/2003WO2002064781A3 Regulation of amyloid precursor protein expression by modification of abc transporter expression or activity
06/26/2003WO2002060340A3 Method for identifying maxi-k channel blockers
06/26/2003WO2002046385A3 Enzymes
06/26/2003WO2002016597A3 Lipid metabolism enzymes
06/26/2003US20030120080 Such as (2S)-2-((4S)-4-(2,2-difluorovinyl)-2-oxopyrrolidinyl) butanamide; antiepileptic agents; anticonvulsants
06/26/2003US20030120072 Such as (4-(3,4-Difluoro-phenyl)-piperazin-1-yl)-((4S ,4aS,8aR)-2-((S)-3-(6-methoxy-pyridin-3-yl)-2-methyl-propyl)-decahydro -isoquinolin-4yl)-methanone for treatment of schizophrenia, depression, anxiety and bipolar disorders
06/26/2003US20030120070 Serotonin 5-HT1A and dopamin D2 receptor ligands
06/26/2003US20030120068 Reacting 2-amino-3-hydroxymethyl or 3-halomethyl pyridine with N-methyl-1-phenyl-2,2'-iminodiethyl halogen to form 1-(3-hydroxy methylpyridyl-2)-4-methyl-2-phenyl-piperazine, and adding a ring closing reagent
06/26/2003US20030120059 Cell surface molecule-induced macrophage activation
06/26/2003US20030119903 Use of trimebutine for treating pain
06/26/2003US20030119878 A 1-arylalkyl-3-aminoalkyl-1,4-dihydropyrid-4-one derivative; sexual disorders; anticarcinogenic agents; benign prostatic hypertrophy/fibroids of the uterus; endometriosis, polycystic ovarian disease, precocious puberty; contraceptives
06/26/2003US20030119877 Pyridine derivatives useful as cyclooxygenase inhibitor
06/26/2003US20030119872 Process for preparing non-hygroscopic sodium valproate composition
06/26/2003US20030119870 2-(Pyrid-2- or 4-yl)-1,2,3,4-tetrahydroisoquinoline and derivatives; a good affinity to the NMDA receptor (N-methyl-D-asparate); acute/cronic neurodegenerative diseases; bacterial/viral infections; antidepressants; analgesics
06/26/2003US20030119869 1-(Piperidin-4-yl)benzimidazole or -triazole derivatives; agonists and antagonist for beta-chemokine (chemotactic cytokines) receptors; viricides; HIV; antiarthritic agents; atherosclerosis, psoriasis, antiallergens; multiple sclerosis
06/26/2003US20030119858 Conformationally constrained compounds as pharmaceutical agents
06/26/2003US20030119855 Heterocycle derivatives and drugs
06/26/2003US20030119854 Compounds and methods for modulating CXCR3 function
06/26/2003US20030119851 In the treatment or prevention of psychotic disorders such as schizophrenia psychotic depression, mania and other central nervous system diseases
06/26/2003US20030119849 Piperazine and piperidine compounds
06/26/2003US20030119847 Heteroaryl derivatives as superior ligands for nociceptin receptor ORL-1
06/26/2003US20030119845 4-((4-benzyl(or methyl heteroaryl)-,1-piperazinyl)(8-quinolinyl)methyl)-N,N-diethylbenzamide or salt, useful for pain treatment
06/26/2003US20030119844 Bind with high selectivity and/ or high affinity to CRF1 receptors (Corticotropin Releasing Factor 1 Receptors), useful for treating psychiatric and neurological diseases, including depression, anxiety and post trauma stress
06/26/2003US20030119842 Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines
06/26/2003US20030119841 Treatment and prevention of anxiety and convulsive disorders
06/26/2003US20030119840 4-Heteroparyl-1,4-diazabicyclo[3.2.2]nonane, preparation and therapeutic use thereof
06/26/2003US20030119837 Pharmaceutical composition for the treatment of CNS and other disorders
06/26/2003US20030119836 Cyclooxygenase inhibitors
06/26/2003US20030119835 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents
06/26/2003US20030119829 4-amino-5,6-substituted thiopheno [2,3-d] pyrimidines, pharmaceutical compositions containing the same, and their use in the treatment or prevention of PDE7B-mediated diseases and conditions
06/26/2003US20030119827 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases
06/26/2003US20030119826 Neuroprotective treatment methods using selective iNOS inhibitors
06/26/2003US20030119825 Highly concentrated stable meloxicam solutions for needleless injection
06/26/2003US20030119821 Benzodiazepine-3-carboxamide derviatives
06/26/2003US20030119820 Substituted indoles
06/26/2003US20030119818 CRF antagonistic quino-and quinazolines
06/26/2003US20030119816 Cycline-dependent kinase protein inhibitors; antiproliferative agents
06/26/2003US20030119815 Lactams substituted by cyclic succinates as inhibitors of A-beta protein production
06/26/2003US20030119811 Ion channel antagonists that are NMDA antagonists; treatment of migraine, depression, anxiety, schizophrenia, Parkinson's disease, or stroke.
06/26/2003US20030119810 Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
06/26/2003US20030119800 Administering an ANGELS (Activators of Non-Genotropic Estrogen-like Signaling compound"ANGELS") compound to maintain or increase bone mass, bone density and/or bone strength.
1 ... 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 ... 1833